Ledger.Open graph →
SEC Form D · filed October 2, 2019

MediSix Therapeutics, Inc

Offering
$20.4M
Sold
$20.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SINGAPORE, U0
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

William A. Harrington · Singapore, U0DirectorGeorge H. Poste · Singapore, U0DirectorMichael A. Carusi · Singapore, U0DirectorSarah D. Lim · Singapore, U0ExecKenneth D. Noonan · Singapore, U0Exec · DirectorWilliam A. Harrington · Singapore, U0DirectorGeorge H. Poste · St. Louis, MODirectorMichael A. Carusi · Singapore, U0DirectorSarah D. Lim · Singapore, U0ExecKenneth D. Noonan · Singapore, U0Exec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗